neoadjuvant pembro chemo vs placebo chemo, followed by adjuvant pembro vs placebo for early-...
Published 2 years ago • 58 plays • Length 5:25Download video MP4
Download video MP3
Similar videos
-
3:49
keynote-522: neoadjuvant pembro chemo vs placebo chemo, followed by adjuvant pembro vs place...
-
9:16
keynote-522: pembro ct vs placebo ct neoadjuvant followed adjuvant pembro vs placebo in tnbc
-
4:54
keynote-522 updates: pembrolizumab plus neoadjuvant chemotherapy in early triple-negative breast...
-
1:46
exploratory analysis of keynote-522: efs after neoadjuvant pembro chemo vs chemo for early tnbc
-
3:44
pembro plus chemo followed by resection and adjuvant pembro improves on soc for early nsclc
-
3:09
keynote-522: neoadjuvant and adjuvant pembrolizumab for early tnbc
-
9:02
phase 3 keynote-522 results: pembro/chemo neoadjuvant, pembro adjuvant in early tnbc
-
4:24
comment: pembro plus chemo in neoadjuvant and adjuvant treatment for early triple-negative breas...
-
4:20
keynote 522: pembrolizumab as neoadjuvant treatment for early tnbc
-
9:59
gs1-01: "phase 3 study of pembrolizumab chemotherapy vs placebo chemotherapy as neoadjuvant..."
-
5:33
keynote-564: pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for patients with...
-
7:18
keynote-826: pembrolizumab chemotherapy vs placebo chemotherapy for cervical cancer
-
7:15
pathologic complete response rates improved with the neoadjuvant and adjuvant treatment of pembr...
-
2:05
adding nivolumab to neoadjuvant chemo improves response rate for high risk er her2− breast cancer
-
0:29
adjuvant treatment for high risk hr breast cancer | esmo 2023 breast cancer highlights
-
13:03
early tnbc - pembrolizumab chemotherapy: pathologic complete response in key subgroups
-
27:18
adjuvant and neoadjuvant dilemmas
-
4:20
keynote-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer
-
38:22
adjuvant/neoadjuvant therapy for breast cancer: updates and molecular predictors of benefit